Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 3, 2025

Stocks Recover on Fed Rate Cut Expectations

View original at nasdaq.com
Stocks Recover on Fed Rate Cut Expectations The S&P 500 Index ($SPX) (SPY) today is up by +0.18%, the Dow Jones Industrials Index ($DOWI) (DIA) is up by +0.47%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down by -0.06%…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Q3 adjusted EPS forecasted at 40 cents, above consensus of 37 cents

    80% confidence
  • Upgraded Vertex Pharmaceuticals to overweight from equal weight with price target of $516

    80% confidence
  • Forecasted Q4 operating income of $220 million to $230 million, above consensus of $214.5 million

    80% confidence
  • Kevin Hassett is seen as the likely choice to succeed Powell as Fed Chair

    80% confidence
  • Cut full-year adjusted EPS forecast to $1.94-$2.04 from previous estimate of $2.35-$2.45, well below consensus of $2.37

    80% confidence
  • Forecasted Q4 revenue of $251 million to $252 million, midpoint below consensus of $251.9 million

    80% confidence
  • He will announce his selection for the new Fed Chair in early 2026

    80% confidence
  • Raised 2026 comparable sales growth forecast to low single digits from previous estimate of flat

    80% confidence
  • Q3 earnings rose 14.6%, more than doubling expectations of 7.2% y/y

    80% confidence
  • Upgraded Astera Labs to buy with price target of $275

    80% confidence
  • Upgraded Stellantis to buy from neutral with price target of $12

    80% confidence
  • Microsoft is reducing its AI software sales quotas amid consumer resistance to newer products

    80% confidence
  • 83% of reporting S&P 500 companies exceeded forecasts, on course for the best quarter since 2021

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com